Antonio L. Sanchez

Geographic access as a modifiable determinant of cancer care: perspectives on hub-and-spoke oncology networks, travel burden and time toxicity.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 10, 2026

Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 06, 2026

Dual Immunotherapy for Pericardial Mesothelioma That Developed After a Decade-Long Idiopathic Pericarditis: A Case Report.

Journal: Respirology case reports

Published: March 14, 2025

Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 19, 2024

Optimizing genetic testing strategy for suspected attenuated adenomatous polyposis: effective solutions in public health systems.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 11, 2024

Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 24, 2024

The c.386A>C p.(Asn129Thr) variant in SMAD4 is likely to be pathogenic, causing Juvenile Polyposis Syndrome. A case report of a mosaic variant.

Journal: Molecular genetics & genomic medicine

Published: June 28, 2023

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.

Journal: Thrombosis research

Published: October 27, 2022

Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

Journal: Haematologica

Published: April 29, 2021

Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.

Journal: Molecular cancer therapeutics

Published: July 02, 2014

Geographic access as a modifiable determinant of cancer care: perspectives on hub-and-spoke oncology networks, travel burden and time toxicity.

Geographic access as a modifiable determinant of cancer care: perspectives on hub-and-spoke oncology networks, travel burden and time toxicity.

Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence.

Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence.

Dual Immunotherapy for Pericardial Mesothelioma That Developed After a Decade-Long Idiopathic Pericarditis: A Case Report.

Dual Immunotherapy for Pericardial Mesothelioma That Developed After a Decade-Long Idiopathic Pericarditis: A Case Report.

Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Optimizing genetic testing strategy for suspected attenuated adenomatous polyposis: effective solutions in public health systems.

Optimizing genetic testing strategy for suspected attenuated adenomatous polyposis: effective solutions in public health systems.

Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

The c.386A>C p.(Asn129Thr) variant in SMAD4 is likely to be pathogenic, causing Juvenile Polyposis Syndrome. A case report of a mosaic variant.

The c.386A>C p.(Asn129Thr) variant in SMAD4 is likely to be pathogenic, causing Juvenile Polyposis Syndrome. A case report of a mosaic variant.

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.

Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

Measurement and Modeling of Narrowband Channels for Ultrasonic Underwater Communications.

Measurement and Modeling of Narrowband Channels for Ultrasonic Underwater Communications.

Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer.

Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer.

Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.

Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.